A 54-amino-acid peptide (with active fragments of 10-54 residues) encoded by the KiSS-1 gene that is the master upstream regulator of the reproductive hormone axis. Kisspeptin neurons in the hypothalamus directly control GnRH pulse generation — determining puberty onset, fertility, and reproductive function.
Kisspeptin is a peptide product of the KiSS-1 gene that serves as the master upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin neurons in the arcuate nucleus of the hypothalamus directly stimulate GnRH neurons, controlling the pulsatile release of GnRH that drives the entire reproductive hormone cascade.
The name 'kisspeptin' comes from the KiSS-1 gene, which was named after Hershey Kisses chocolates because the gene was discovered in Hershey, Pennsylvania (as a metastasis suppressor gene, initially called metastin). Its critical role in reproduction was discovered when loss-of-function mutations in its receptor (GPR54/KISS1R) were found to cause hypogonadotropic hypogonadism — absence of puberty.
Kisspeptin binds to GPR54 (KISS1R), a Gq-coupled GPCR exclusively expressed on GnRH neurons in the hypothalamus. Activation triggers PLC-IP3-Ca²⁺ signaling, depolarizing GnRH neurons and causing GnRH release into the portal blood system. The pulsatile pattern of kisspeptin release (driven by the kisspeptin-neurokinin B-dynorphin (KNDy) neuron network) directly determines the pulsatile pattern of GnRH — which is essential for normal LH/FSH secretion.
| Pathway | Effect | Significance |
|---|---|---|
| GnRH activation | Direct stimulation of GnRH neurons via GPR54 | Master control of the entire reproductive hormone cascade |
| Puberty trigger | Increased kisspeptin expression at puberty onset | Determines timing of sexual maturation |
| LH surge | Kisspeptin from AVPV neurons triggers preovulatory LH surge | Essential for ovulation in females |
| Metabolic gating | Kisspeptin neurons sense leptin, insulin, and energy status | Links nutritional status to reproductive capacity (why underweight → amenorrhea) |
| Stress integration | Cortisol suppresses kisspeptin neurons | Explains stress-induced infertility and amenorrhea |
| Study | Design | Findings | Level |
|---|---|---|---|
| Genetic proof | Human genetics | Loss-of-function mutations in KISS1R cause hypogonadotropic hypogonadism (no puberty). Gain-of-function causes precocious puberty. Definitive proof of function. | Level I (genetic) |
| Fertility treatment | Phase II trials, n=various | Kisspeptin-54 injection triggers LH release in healthy women and men. Being studied as a safer alternative to hCG for IVF trigger. | Level II |
| Hypothalamic amenorrhea | Clinical studies | Kisspeptin infusion restores LH pulsatility in women with hypothalamic amenorrhea | Level II |
| Male hypogonadism | Phase I/II | Kisspeptin injection increases testosterone in men with functional hypogonadism | Level II |
Generally well-tolerated: No significant adverse effects in clinical trials at standard doses.
Short half-life: Kisspeptin-54 has a short half-life (~28 minutes IV). Sustained effects require infusion or long-acting analogs.
Potential for desensitization: Like GnRH, continuous kisspeptin exposure may cause receptor desensitization. Pulsatile administration is likely needed.
| Jurisdiction | Status |
|---|---|
| FDA | Not approved. Clinical trials ongoing for IVF applications. |
| Research | One of the most active areas of reproductive endocrinology research |
| Significance | Potential to replace hCG trigger in IVF (lower OHSS risk) and treat functional hypothalamic amenorrhea |